greeksoup/ stock research

Addus HomeCare Corp.: Q4 FY2025 earnings call

What management said about Q4 FY2025, from the documents filed with the SEC on 23 February 2026: press release. The quarter’s numbers.

Key takeaways

  • Revenue rose 25.6% in quarter: Net service revenues were $373.1 million against $297.1 million, and net income was $29.8 million, or $1.61 per diluted share, against $1.07. Source
  • Adjusted EBITDA up 33.3%: Adjusted EBITDA was $50.3 million against $37.8 million; adjusted net income per diluted share was $1.77 against $1.38, up 28.3%. Source
  • Personal care drove growth: Personal care revenue was $286.0 million, 76.6% of the quarter, against $220.3 million a year earlier, with organic growth in the segment. Source
  • Hospice grew 16.0% organically: Hospice revenue was $70.0 million, 18.8% of the quarter, with 16.0% organic growth; management cited operational improvements over the past year. Source
  • Gross margin eased to 33.1%: Gross margin was 33.1% of revenue against 34.2% a year earlier; full-year gross margin was 32.5% in both years. Source
  • Operating cash flow $18.8 million: Operating cash flow was $18.8 million for the quarter and $111.5 million for the year, against $116.4 million in 2024. Source
  • Cash and revolver availability: Year-end cash was $81.6 million and bank debt $124.3 million; $517.7 million was available of the $650.0 million revolving facility. Source
  • Acquisitions remain central to growth: Management said acquisitions remain integral to growth; three were completed in 2025, and the development team is working on density in strategic markets. Source

“Our favorable results for 2025 affirm our strategic priorities, and we will continue to extend our market reach through both organic growth and acquisitions in the year ahead.”

Dirk Allison, Chairman and Chief Executive Officer

What changed from last quarter

  • New: The State of Illinois, the largest personal care market, announced a 3.9% increase effective January 1, 2026. Source
  • New: Adjusted measures now also exclude lease impairment, New York retroactive rate increases and New York receivable settlements; the Q3 definitions did not. Source

Quarter results and growth

  • Revenue rose 25.6% in quarter: Net service revenues were $373.1 million against $297.1 million, and net income was $29.8 million, or $1.61 per diluted share, against $1.07. Source
  • Adjusted EBITDA up 33.3%: Adjusted EBITDA was $50.3 million against $37.8 million; adjusted net income per diluted share was $1.77 against $1.38, up 28.3%. Source
  • Full-year revenue reached $1.42 billion: Full-year net service revenues were $1.42 billion, up 23.2%; full-year net income was $95.9 million, or $5.22 per diluted share, against $4.23. Source
  • Adjusted results exclude settlement items: Adjusted results remove New York receivable settlements tied to divested operations, a $(0.07) per diluted share effect in the quarter, with $1.9 million in the EBITDA reconciliation. Source

Segments and service lines

  • Personal care drove growth: Personal care revenue was $286.0 million, 76.6% of the quarter, against $220.3 million a year earlier, with organic growth in the segment. Source
  • Hospice grew 16.0% organically: Hospice revenue was $70.0 million, 18.8% of the quarter, with 16.0% organic growth; management cited operational improvements over the past year. Source
  • Home health revenue declined: Home health revenue was $17.1 million, 4.6% of the quarter, down from $17.8 million; organic revenue fell 7.4%. Source

“We are optimistic that we will see additional acquisition opportunities in 2026.”

Dirk Allison, Chairman and Chief Executive Officer

Rates, payor mix and pricing

  • Texas rate rose 9.9%: The Texas rate rose 9.9% effective September 1, 2025; with Gentiva and Del Cielo added, Texas is now the second-largest personal care market. Source
  • Managed care share rose: Managed care organizations were 47.3% of personal care revenue against 43.1%; state, local and government programs were 49.9% against 54.2%. Source
  • Revenue per billable hour fell: Revenue per billable hour in personal care was $25.70 against $26.40 a year earlier, while the segment's organic growth was supported by volumes and higher rates. Source

Costs, margins and expenses

  • Gross margin eased to 33.1%: Gross margin was 33.1% of revenue against 34.2% a year earlier; full-year gross margin was 32.5% in both years. Source
  • G&A expenses rose in dollars: General and administrative expenses were $77.2 million against $71.4 million; stock-based compensation was $4.5 million against $2.9 million. Source
  • Acquisition expenses fell: Acquisition expenses were $1.2 million against $7.0 million; full-year acquisition expenses were $8.9 million against $14.7 million. Source
  • Operating income and interest rose: Operating income was $42.3 million against $26.9 million; net interest expense was $2.1 million against $0.7 million. Source

“We recognize the success of our operations and continued growth reflect the hard work and dedication of the caregivers who are the face of Addus”

Dirk Allison, Chairman and Chief Executive Officer

Demand, census and workforce

  • Hiring trends described as stable: Management described continued favorable and stable hiring trends as supporting the business, especially in personal care. Source
  • Personal care billable hours rose: Personal care billable hours were 11.1 million against 8.2 million in the quarter; full-year billable hours were 42.7 million against 31.3 million. Source
  • Hospice admissions and daily rate up: Hospice admissions were 3,180 against 3,095, and revenue per patient day was $193.46 against $185.95. Source

Cash, debt and capital

  • Operating cash flow $18.8 million: Operating cash flow was $18.8 million for the quarter and $111.5 million for the year, against $116.4 million in 2024. Source
  • Cash and revolver availability: Year-end cash was $81.6 million and bank debt $124.3 million; $517.7 million was available of the $650.0 million revolving facility. Source
  • Long-term debt declined: Management said cash flow went to paying down debt; long-term debt, net of issuance costs, was $121.0 million against $218.4 million a year earlier. Source

Acquisitions, strategy and technology

  • Acquisitions remain central to growth: Management said acquisitions remain integral to growth; three were completed in 2025, and the development team is working on density in strategic markets. Source
  • Technology spending continues: Management said capital goes first to acquisitions while technology spending continues to support operations and caregivers. Source
  • Care continuum drives synergies: Management said offering multiple levels of care creates synergies as scale grows, and home health serves as a clinical partner to personal care and hospice. Source

Figures management reported

FigureReported
Patients and consumers served Sourceapproximately 62,500
Personal care organic revenue growth Source6.3%
Personal care billable hours per census per month Source72.3 vs 69.6
Hospice average discharge length of stay Source104.2 vs 97.9
Home health visits Source86,304 vs 99,803

Earlier plans management reported on

  • Not stated: The Q3 release expected Del Cielo to be accretive; the Q4 release says the acquired operations are included in results but does not state accretion.

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.